Top compounds associated with response to ASB18


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC 0.079 0.02
mRNA BRD8958 CTRPv2 pan-cancer AAC 0.089 0.02
mRNA pifithrin-alpha CTRPv2 pan-cancer AAC 0.085 0.02
mRNA masitinib CTRPv2 pan-cancer AAC 0.082 0.02
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.12 0.02
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.082 0.02
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.083 0.02
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.02
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.02
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.02
Download CSV